BCL2 Expression and BCL2/MYC Dual Expression Correlates with Inferior Survival in Primary Central Nervous System Lymphoma

被引：0
|
作者：
Uppal, G.
Wang, Z-X
Bajaj, R.
Curtis, M.
Solomides, C. C.
Glass, J.
Banks, P.
Peiper, S. C.
Gong, J. Z.
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Ventana Med Syst Inc, Tucson, AZ USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1571
引用
收藏
页码：383A / 383A
页数：1
相关论文
共 50 条
  • [21] MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas
    Huang, Wenting
    Medeiros, L. Jeffrey
    Lin, Pei
    Wang, Wei
    Tang, Guilin
    Khoury, Joseph
    Konoplev, Sergej
    Yin, C. Cameron
    Xu, Jie
    Oki, Yasuhiro
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 (09) : 1470 - 1478
  • [22] BCL2 Expression Correlates With Surface Immunoglobulin Levels and Prognosis in Follicular Lymphoma Patients
    Barreca, A.
    Martinengo, C.
    Righi, L.
    Chiappella, A.
    Ladetto, M.
    Chiusa, L.
    Stacchini, A.
    Chiarle, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S649 - S649
  • [23] MYC and BCL2 Gene Rearrangements in Comparison to MYC and BCL2 Protein Expression in AIDS-Related Diffuse Large B Cell Lymphomas
    Nam, Anna
    Mathew, Susan
    Liu, Yen-Chun
    Chadburn, Amy
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [24] Central nervous system and head and neck imaging findings of MYC/BCL2 "double hit" B cell lymphoma
    Khaleel, Ziyad L.
    Wright, Mathew P.
    Quigley, Edward
    Singh, T. J.
    Jones, Randall
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (02) : 326 - 327
  • [25] Impact of BCL2/MYC Protein Dual Expression and Other Clinical Factors on the Risk of Central Nervous System Progression in Patients with Primary Breast Diffuse Large B-Cell Lymphoma
    Yhim, Ho-Young
    Yoon, Dok-Hyun
    Jang, Kyu Yun
    Yang, Deok-Hwan
    Yoon, Sang Eun
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon-Seok
    Kim, Kyoung Ha
    Kang, Ka-Won
    Do, Young Rok
    Lee, Soon Il
    Kim, Hyo Jung
    Ahn, Ae Ri
    Song, Ga-Young
    Lee, Han Sang
    Lee, Hyewon
    Kim, Seok Jin
    Kim, Won Seog
    Suh, Cheolwon
    Kwak, Jae-Yong
    BLOOD, 2022, 140 : 9498 - 9499
  • [26] Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth
    Morris, G
    DeNardo, SJ
    DeNardo, GL
    Leshchinsky, T
    Wu, BA
    Mack, PC
    Winthrop, MD
    Gumerlock, PH
    BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 60 (02) : 108 - 115
  • [27] Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
    Barouqa, Mohammad
    Greipp, Patricia
    King, Rebecca
    McPhail, Ellen D.
    EJHAEM, 2022, 3 (03): : 1080 - 1081
  • [28] MYC translocation partner determines survival in double-hit BCL2/MYC lymphoma
    Pedersen, M. O.
    Gang, A. O.
    Poulsen, T. S.
    Knudsen, H.
    Lauritzen, A. F.
    Gang, U. O.
    Nielsen, S. L.
    Norgaard, P. H.
    APMIS, 2012, 120 : 6 - 7
  • [29] Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
    Schneider, Kelli M. Clark
    Banks, Peter M.
    Collie, Angela M. B.
    Lanigan, Christopher P.
    Manilich, Elena
    Durkin, Lisa M.
    Hill, Brian T.
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1640 - 1648
  • [30] Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements
    Ikoma, Haruka
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Kikuti, Yara Yukie
    Shiraiwa, Sawako
    Hara, Ryujiro
    Kojima, Minoru
    Ohmachi, Ken
    Ando, Kiyoshi
    Carreras, Joaquim
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2022, 72 (06) : 321 - 331
12345